Table 2.

Life expectancy (LE), health-adjusted life expectancy (HALE) (With 95% Confidence Intervals), and Loss of LE and HALE at selected ages, by hypertension (HTN) status and sex, Canada, 2004 to 2006. (Dataset for this study excluded Quebec, Nunavut and Northwest Territories.)

Sex	Life expectancy measure	Without HTN (I)	With HTN (II)	Loss of life expectancy associated with HTN (I-II)
At age 20 years
Females	LE	65.4 (65.3-65.4)	62.1 (61.9–62.4)	3.3*
	HALE	55.0 (54.6–55.3)	48.9 (48.1–49.7)	6.1*
	LE-HALE	10.4*	13.2*
	(LE-HALE)/LE	0.16	0.21
Males	LE	61.0 (61.0-61.0)	56.9 (56.7–57.2)	4.1*
	HALE	52.8 (52.5–53.1)	47.1 (46.3–47.8)	5.7*
	LE-HALE	8.2*	9.8*
	(LE-HALE)/LE	0.13	0.17
At age 55 years
Females	LE	31.6 (31.6-31.7)	30.1 (30.1-30.2)	1.5*
	HALE	24.7 (24.4–25.1)	22.7 (22.3–23.0)	2.0*
	LE-HALE	6.9*	7.4*
	(LE-HALE)/LE	0.22	0.25
Males	LE	28.0 (28.0-28.1)	25.9 (25.8-25.9)	2.1*
	HALE	22.9 (22.6–23.2)	20.2 (19.8–20.6)	2.7*
	LE-HALE	5.1*	5.7*
	(LE-HALE)/LE	0.18	0.22
At age 85 years
Females	LE	8.6	8.5	0.1
	HALE	5.2	4.9	0.3
	LE-HALE	3.4	3.6
	(LE-HALE)/LE	0.40	0.42
Males	LE	6.9	6.5	0.4
	HALE	4.4	4.0	0.4
	LE-HALE	2.5	2.5
	(LE-HALE)/LE	0.36	0.38

∗Statistically significant at  .05.